Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.42
+0.22 (1.80%)
At close: Sep 3, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 587.31 million as of September 4, 2026. Its market cap has decreased by -18.37% in one year.
Market Cap
587.31M
Enterprise Value
254.07M
Revenue
35.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.42
ChartMarket Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 587.31M, a decrease of -61.29%. That is a compound annual growth rate of -34.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 578.00M | -35.51% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.36B |
| Nanexa AB | 1.14B |
| Dicot Pharma AB | 793.64M |
| EQL Pharma AB | 761.86M |
| Moberg Pharma AB | 531.26M |
| Orexo AB | 525.92M |
| Enzymatica AB | 445.42M |
| Klaria Pharma Holding AB (publ.) | 156.19M |